NCT03259880

Brief Summary

Acute pancreatitis (AP) is rapid-onset inflammation of the pancreas that varies in severity from a self-limiting mild illness to rapidly progressive multiple organ failure. Statistics suggest that 10-20% of patients with AP develop severe AP (SAP),1 which usually has an unfavourable disease progression and is associated with a poor prognosis. The two most common and important causes of acute pancreatitis are gallstones (40-70%) and alcohol (25-35%) Gallstone pancreatitis is usually due to an obstructing stone in the pancreatic duct near the sphincter of Oddi . In alcohol-related pancreatitis, it is believed that the acinar cells of the pancreas are susceptible to damage by ethanol and underlie the etiology of the disease . Another common cause, iatrogenic pancreatitis, may occur after endoscopic retrograde cholangiopancreatography (ERCP) in up to 5% of patients. Other etiologies of acute pancreatitis include medications, infections, trauma, hereditary, hypertriglyceridemia and autoimmune disease.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2017

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 18, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 24, 2017

Completed
8 days until next milestone

Study Start

First participant enrolled

September 1, 2017

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2018

Completed
Last Updated

August 24, 2017

Status Verified

July 1, 2017

Enrollment Period

1 year

First QC Date

August 18, 2017

Last Update Submit

August 23, 2017

Conditions

Keywords

evaluation

Outcome Measures

Primary Outcomes (3)

  • evaluation of the prognostic value of neutrophil _lymphocyte ratio in cbc in patients with acute pancreatitis admitted at assiut university hospitals.

    evaluation of the prognostic value neutrophil lymphocyte ratio in patient with acute pancreatitis

    one year

  • evaluation of the prognostic value of LDH in patients with acute pancreatitis admitted at assiut university hospitals.

    evaluation of the prognostic value of LDH ratio in patient with acute pancreatitis

    one year

  • evaluation of the prognostic value of urine analysis in patients with acute pancreatitis admitted at assiut university hospitals.

    evaluation of the prognostic value of urine analysis ratio in patient with acute pancreatitis

    one year

Eligibility Criteria

Age16 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Evaluation of the best prognostic parameter in patients with acute pancreatitis

You may qualify if:

  • patients with acute pancreatitis admitted at Assiut university hospital and the diagnosis of acute pancreatitis is confirmed if at least two of the following three features present:
  • abdominal pain characteristic of acute pancreatitis.
  • serum amylase and/or lipase greater than 3 times the upper limit of normal .
  • radiographically demonstrated acute pancreatitis on CT scan or abdominal ultrasound.

You may not qualify if:

  • Patients are excluded from the study if they do not meet the criteria for acute pancreatitis
  • Patients who are under the age of 16.
  • Patients with chronic pancreatitis.
  • Patients with recurrent acute pancreatitis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pancreatitis

Condition Hierarchy (Ancestors)

Pancreatic DiseasesDigestive System Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
internal medicine resident,Assiut University hospital

Study Record Dates

First Submitted

August 18, 2017

First Posted

August 24, 2017

Study Start

September 1, 2017

Primary Completion

September 1, 2018

Study Completion

September 1, 2018

Last Updated

August 24, 2017

Record last verified: 2017-07